Filing search / Guardion Health Sciences, Inc. / "Commitment"

DEFM14A

GHSI Guardion Health Sciences, Inc.

8 Apr 24

Proxy related to merger

4:28pm

will not have incurred, any obligation, condition, commitment, restriction or liability of any kind that would impair or adversely affect such resources … , Debt Breakage Costs, commitment and other fees, costs and expenses in respect of (A) indebtedness of such Person or its Subsidiaries for borrowed

PREM14A

GHSI Guardion Health Sciences, Inc.

20 Mar 24

Preliminary proxy related to merger

8:15pm

, and (iii) has not incurred, and as of the Closing will not have incurred, any obligation, condition, commitment, restriction or liability of any kind … principal amount of, accrued or unpaid interest of, premium, Debt Breakage Costs, commitment and other fees, costs and expenses in respect of (A) indebtedness

425

EX-10.1

GHSI Guardion Health Sciences, Inc.

31 Jan 24

Business combination disclosure

5:21pm

its obligations hereunder, and (iii) has not incurred, and as of the Closing will not have incurred, any obligation, condition, commitment … duplication, (i) the outstanding principal amount of, accrued or unpaid interest of, premium, Debt Breakage Costs, commitment and other fees, costs and expenses

425

EX-99.1

GHSI Guardion Health Sciences, Inc.

31 Jan 24

Business combination disclosure

5:21pm

underscores our commitment to continue to invest in strategically aligned opportunities that create manufacturing and marketing synergies. The strength

8-K

EX-10.1

idbq48 62v68

31 Jan 24

Entry into a Material Definitive Agreement

5:18pm

8-K

EX-99.1

2ple0

31 Jan 24

Entry into a Material Definitive Agreement

5:18pm

8-K

EX-99.1

ipdsfo3j

20 Apr 23

Results of Operations and Financial Condition

4:15pm

8-K

EX-99.1

ate95fo

14 Nov 22

Guardion Health Sciences Announces Financial Results

5:16pm

424B5

xk1hrzo4wdxmuecj9

24 Feb 22

Prospectus supplement for primary offering

4:30pm

424B5

m4035340tfi1nw73jlk

22 Feb 22

Prospectus supplement for primary offering

5:28pm

424B5

gh7ofc1ug8ykv4n

17 Feb 22

Prospectus supplement for primary offering

8:30am

424B5

qn8tyzo

28 Jan 22

Prospectus supplement for primary offering

4:51pm

8-K

EX-10.1

vqreia1s7oo66oduhija

21 May 21

Acquisition to Transform and Strengthen Guardion’s Clinical Nutrition Product Portfolio

4:05pm

424B5

i8l8 hrdb

28 Jan 21

Prospectus supplement for primary offering

5:14pm

424B5

x7eozqs

8 Jan 21

Prospectus supplement for primary offering

8:29am

8-K

EX-99.1

itytr

13 Nov 20

Guardion Health Sciences Announces Financial Results

12:49pm

S-3

7sv20jxolmxtys09

18 Sep 20

Shelf registration

3:21pm